Icu Medical (ICUI) Cost of Revenue (2009 - 2026)

Icu Medical (ICUI) has reported Cost of Revenue for 18 consecutive years, with $316.6 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Cost of Revenue fell 7.09% year-over-year to $316.6 million; the trailing twelve-month figure through Jun 2026 stood at $1.3 billion (down 13.65% YoY), and the FY2025 full-year result was $1.4 billion, down 9.51% from the prior year.
• Cost of Revenue declined to $316.6 million in Q2 2026 per ICUI's latest filing, from $324.0 million in the prior quarter.
• Across five years, Cost of Revenue topped out at $416.3 million in Q4 2023 and bottomed at $316.6 million in Q2 2026.
• Historically, Cost of Revenue has averaged $372.7 million across 5 years, with a median of $379.0 million in 2023.
• The sharpest annual moves came in 2022 and 2026: Cost of Revenue surged 98.54% in 2022, then fell 17.89% in 2026.
• Over 5 years, Cost of Revenue stood at $403.1 million in 2022, then advanced by 3.28% to $416.3 million in 2023, then slipped by 3.3% to $402.5 million in 2024, then dropped by 16.1% to $337.7 million in 2025, then decreased by 6.24% to $316.6 million in 2026.
• According to Business Quant data, Cost of Revenue over the past three periods registered $316.6 million, $324.0 million, and $337.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.